X

Xencor
D

XNCR

25.020
USD
0.93
(3.86%)
Market Closed
Volume
25,025
EPS
-3
Div Yield
-
P/E
-8
Market Cap
1,750,950,391
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    C
    CLDT
    -0.13500
    (-1.50%)
    8.86000 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    T
    TGTX
    -1.325
    (-4.30%)
    29.515 USD
    More
News

Title: Xencor

Sector: Healthcare
Industry: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.